glp 1 agonist for weight loss GLP-1 drugs leave users low on key nutrients, study finds Interest in Treatment with GLP-1
Description
10.1016/j.cardfail.2019.05.007 23 ElsanhouryA.NelkiV.KelleS.Van LinthoutS.TschpeC
The following four molecular pathways collectively describe how GLP-1RAs facilitate retinal remodeling, primarily by enhancing vascular function and restoring ECM homeostasis
Scientists identified two main hormones responsible: Glucose-dependent Insulinotropic Polypeptide (GIP) and Glucagon-like Peptide (GLP-1)
Glucagon-like peptide-1 affects gene transcription and messenger ribonucleic acid stability of components of the insulin secretory system in RIN 1046-38 cells
Among GLP-1RA users, 26.36% discontinued treatment during follow-up, while 22.68% experienced interruptions
